Xiaoyue Bi

675 total citations
23 papers, 331 citations indexed

About

Xiaoyue Bi is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Xiaoyue Bi has authored 23 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 12 papers in Hepatology and 6 papers in Molecular Biology. Recurrent topics in Xiaoyue Bi's work include Hepatitis B Virus Studies (11 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis C virus research (10 papers). Xiaoyue Bi is often cited by papers focused on Hepatitis B Virus Studies (11 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis C virus research (10 papers). Xiaoyue Bi collaborates with scholars based in China and United States. Xiaoyue Bi's co-authors include Minghui Li, Yanjie Lin, Yao Xie, Wei Yi, Mengjiao Xu, Zhan Zeng, Yuanjiao Gao, Hongxiao Hao, Lu Zhang and Yang Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Frontiers in Microbiology.

In The Last Decade

Xiaoyue Bi

23 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoyue Bi China 9 122 75 69 40 40 23 331
Parisa Farrokh Iran 9 189 1.5× 30 0.4× 23 0.3× 33 0.8× 13 0.3× 24 366
Harpreet Singh India 11 110 0.9× 87 1.2× 47 0.7× 6 0.1× 11 0.3× 72 433
Yao Yang China 12 161 1.3× 37 0.5× 25 0.4× 24 0.6× 19 0.5× 27 446
Zhan Zeng China 7 81 0.7× 64 0.9× 57 0.8× 29 0.7× 40 1.0× 22 242
Anna Ballard United States 10 154 1.3× 67 0.9× 42 0.6× 20 0.5× 20 0.5× 14 397
Yuanjiao Gao China 7 84 0.7× 98 1.3× 90 1.3× 16 0.4× 40 1.0× 15 266
Shanjun Gao China 12 311 2.5× 55 0.7× 17 0.2× 20 0.5× 16 0.4× 20 572
Julie Laurent France 11 157 1.3× 44 0.6× 25 0.4× 12 0.3× 10 0.3× 16 388
Gayatree Mohapatra India 8 141 1.2× 57 0.8× 36 0.5× 36 0.9× 14 0.3× 12 347
Yuankui Chu China 12 244 2.0× 35 0.5× 8 0.1× 11 0.3× 20 0.5× 23 510

Countries citing papers authored by Xiaoyue Bi

Since Specialization
Citations

This map shows the geographic impact of Xiaoyue Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyue Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyue Bi more than expected).

Fields of papers citing papers by Xiaoyue Bi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyue Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyue Bi. The network helps show where Xiaoyue Bi may publish in the future.

Co-authorship network of co-authors of Xiaoyue Bi

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyue Bi. A scholar is included among the top collaborators of Xiaoyue Bi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyue Bi. Xiaoyue Bi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xinxin, Weihua Cao, Ziyu Zhang, et al.. (2024). Nanoparticles and their application in the diagnosis of hepatocellular carcinoma. Nanotechnology Reviews. 13(1). 1 indexed citations
2.
Zhang, Ziyu, Weihua Cao, Xinxin Li, et al.. (2024). Nanoparticles and the treatment of hepatocellular carcinoma. Nanotechnology Reviews. 13(1). 1 indexed citations
3.
Wu, Shuling, Yang Liu, Xiaoyue Bi, et al.. (2023). Attach importance to antiviral therapy in patients with hepatocellular carcinoma caused by hepatitis virus. SHILAP Revista de lepidopterología. 1(1). 5–10. 2 indexed citations
4.
Zhang, Lu, Yang Liu, Yuanjiao Gao, et al.. (2023). Nomogram for evaluating obvious liver inflammation in treatment-naïve HBeAg positive chronic hepatitis B virus infection patients with normal ALT. Virulence. 14(1). 2158710–2158710. 2 indexed citations
5.
Li, Minghui, Fangfang Sun, Xiaoyue Bi, et al.. (2022). Effects of antiviral therapy and drug withdrawal on postpartum hepatitis in pregnant women with chronic HBV infection. Hepatology International. 17(1). 42–51. 5 indexed citations
6.
Chen, Xiaoxue, Wei Yi, Yang Liu, et al.. (2022). Pathway of Cell Death and Its Role in Virus Infection. Viral Immunology. 35(7). 444–456. 8 indexed citations
7.
Wu, Shuling, et al.. (2022). Severe coagulopathy caused by cefminox sodium in a liver cirrhosis patient: a case report. Infectious Agents and Cancer. 17(1). 30–30. 4 indexed citations
8.
Xu, Mengjiao, Yang Liu, Yanjie Lin, et al.. (2022). Emerging nanobiotechnology for precise theranostics of hepatocellular carcinoma. Journal of Nanobiotechnology. 20(1). 427–427. 36 indexed citations
9.
Cao, Weihua, Lu Zhang, Xiaoyue Bi, et al.. (2022). Expression of Functional Molecule on Plasmacytoid Dendritic Cells Is Associated With HBsAg Loss in HBeAg-Positive Patients During PEG-IFN α-2a Treatment. Frontiers in Immunology. 13. 891424–891424. 5 indexed citations
10.
Hao, Hongxiao, Tingting Jiang, Wen Deng, et al.. (2022). Effect of Antiviral Therapy During Pregnancy on Natural Killer Cells in Pregnant Women With Chronic HBV Infection. Frontiers in Immunology. 13. 893628–893628. 4 indexed citations
11.
Zeng, Zhan, Wei Yi, Qiqi Chen, et al.. (2022). Baseline lymphocyte and cholinesterase levels may be the predictors of chronic herbal drug–induced liver injury. Frontiers in Pharmacology. 13. 962480–962480. 2 indexed citations
12.
Li, Minghui, Xiaoyue Bi, Fangfang Sun, et al.. (2022). An optimized mode of interferon intermittent therapy help improve HBsAg disappearance in chronic hepatitis B patients. Frontiers in Microbiology. 13. 960589–960589. 3 indexed citations
13.
Li, Minghui, Yuanjiao Gao, Yang Liu, et al.. (2022). Dynamic changes of cytokine profiles and virological markers during 48 weeks of entecavir treatment for HBeAg-positive chronic hepatitis B. Frontiers in Immunology. 13. 1024333–1024333. 4 indexed citations
14.
Li, Minghui, Fangfang Sun, Xiaoyue Bi, et al.. (2022). Consolidation treatment needed for sustained HBsAg-negative response induced by interferon-alpha in HBeAg positive chronic hepatitis B patients. Virologica Sinica. 37(3). 390–397. 18 indexed citations
15.
Wu, Shuling, Wei Yi, Yuanjiao Gao, et al.. (2022). Immune Mechanisms Underlying Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients With Viral Coinfection. Frontiers in Immunology. 13. 893512–893512. 12 indexed citations
16.
Li, Minghui, Fangfang Sun, Zhan Zeng, et al.. (2022). Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B Patients. Frontiers in Immunology. 13. 892031–892031. 10 indexed citations
17.
18.
Liu, Yang, Wei Yi, Mengjiao Xu, et al.. (2021). Application of Lab-on-Chip for Detection of Microbial Nucleic Acid in Food and Environment. Frontiers in Microbiology. 12. 765375–765375. 13 indexed citations
19.
Zhang, Lu, Fengxin Chen, Zhan Zeng, et al.. (2021). Advances in Metagenomics and Its Application in Environmental Microorganisms. Frontiers in Microbiology. 12. 766364–766364. 148 indexed citations
20.
Wu, Xueqing, et al.. (2015). The WNT/β-catenin signaling pathway may be involved in granulosa cell apoptosis from patients with PCOS in North China. Journal of Gynecology Obstetrics and Human Reproduction. 46(1). 93–99. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Parisa Farrokh Breakdown of academic impact, for papers by Harpreet Singh Breakdown of academic impact, for papers by Yao Yang Breakdown of academic impact, for papers by Zhan Zeng Breakdown of academic impact, for papers by Anna Ballard Breakdown of academic impact, for papers by Yuanjiao Gao Breakdown of academic impact, for papers by Shanjun Gao Breakdown of academic impact, for papers by Julie Laurent Breakdown of academic impact, for papers by Gayatree Mohapatra Breakdown of academic impact, for papers by Yuankui Chu
Rankless by CCL
2026